USD 0.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 255 Thousand USD | -97.68% |
2022 | 10.97 Million USD | -62.4% |
2021 | 29.19 Million USD | 728.38% |
2020 | 3.52 Million USD | -80.12% |
2019 | 17.72 Million USD | 19.66% |
2018 | 14.81 Million USD | -6.23% |
2017 | 15.79 Million USD | 148.71% |
2016 | 6.35 Million USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 308.47 USD | -69.38% |
2008 | 1007.40 USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 9000.00 USD | -68.97% |
2024 Q2 | 1000.00 USD | -88.89% |
2023 Q3 | 48 Thousand USD | -96.89% |
2023 FY | 255 Thousand USD | -97.68% |
2023 Q1 | 3.55 Million USD | 325.67% |
2023 Q2 | 1.54 Million USD | -56.56% |
2023 Q4 | 29 Thousand USD | -39.58% |
2022 Q2 | 1.64 Million USD | -65.01% |
2022 Q3 | 162 Thousand USD | -90.15% |
2022 Q4 | -1.57 Million USD | -1071.6% |
2022 Q1 | 4.7 Million USD | -51.33% |
2022 FY | 10.97 Million USD | -62.4% |
2021 Q4 | 9.65 Million USD | 13.02% |
2021 Q2 | 6.22 Million USD | 30.58% |
2021 Q3 | 8.54 Million USD | 37.35% |
2021 FY | 29.19 Million USD | 728.38% |
2021 Q1 | 4.76 Million USD | -20.1% |
2020 Q2 | -10.73 Million USD | -347.77% |
2020 Q4 | 5.96 Million USD | 50.49% |
2020 FY | 3.52 Million USD | -80.12% |
2020 Q1 | 4.33 Million USD | 193.01% |
2020 Q3 | 3.96 Million USD | 136.91% |
2019 Q3 | 7.95 Million USD | -5.22% |
2019 Q4 | -4.65 Million USD | -158.59% |
2019 FY | 17.72 Million USD | 19.66% |
2019 Q1 | 6.04 Million USD | 299.73% |
2019 Q2 | 8.38 Million USD | 38.79% |
2018 Q1 | 5.7 Million USD | 21.03% |
2018 FY | 14.81 Million USD | -6.23% |
2018 Q4 | -3.02 Million USD | -149.58% |
2018 Q3 | 6.1 Million USD | 1.15% |
2018 Q2 | 6.03 Million USD | 5.84% |
2017 Q3 | 7.6 Million USD | 88.91% |
2017 Q4 | 4.71 Million USD | -38.07% |
2017 Q1 | 3.91 Million USD | 4.93% |
2017 FY | 15.79 Million USD | 148.71% |
2017 Q2 | 4.02 Million USD | 2.85% |
2016 Q4 | 3.73 Million USD | 4.47% |
2016 Q1 | - USD | 0.0% |
2016 FY | 6.35 Million USD | 0.0% |
2016 Q2 | 834.52 Thousand USD | 0.0% |
2016 Q3 | 3.57 Million USD | 327.95% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | -100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | -100.0% |
2009 FY | 308.47 USD | -69.38% |
2009 Q4 | 6.29 USD | 0.0% |
2009 Q3 | - USD | -100.0% |
2009 Q2 | 100.78 USD | -38.23% |
2009 Q1 | 163.14 USD | -57.61% |
2008 FY | 1007.40 USD | 0.0% |
2008 Q3 | 600.79 USD | 2558.64% |
2008 Q2 | 22.60 USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | 384.87 USD | -35.94% |
Name | Revenue | Revenue Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 2.92 Billion USD | 99.991% |
Addus HomeCare Corporation | 1.05 Billion USD | 99.976% |
AirSculpt Technologies, Inc. | 195.91 Million USD | 99.87% |
Amedisys, Inc. | 2.23 Billion USD | 99.989% |
American Oncology Network, Inc. | 1.27 Billion USD | 99.98% |
Astrana Health, Inc. | 1.38 Billion USD | 99.982% |
Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 99.987% |
IMAC Holdings, Inc. | 5.19 Million USD | 95.093% |
biote Corp. | 185.36 Million USD | 99.862% |
Cryo-Cell International, Inc. | 31.34 Million USD | 99.186% |
Cross Country Healthcare, Inc. | 2.01 Billion USD | 99.987% |
COMPASS Pathways plc | - USD | -Infinity% |
DocGo Inc. | 624.28 Million USD | 99.959% |
The Ensign Group, Inc. | 3.72 Billion USD | 99.993% |
Healthcare Services Group, Inc. | 1.67 Billion USD | 99.985% |
InnovAge Holding Corp. | 763.85 Million USD | 99.967% |
The Joint Corp. | 117.69 Million USD | 99.783% |
LifeStance Health Group, Inc. | 1.05 Billion USD | 99.976% |
Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | 97.538% |
ModivCare Inc. | 2.75 Billion USD | 99.991% |
NewGenIvf Group Limited | 5.13 Million USD | 95.035% |
Novo Integrated Sciences, Inc. | 12.57 Million USD | 97.972% |
Option Care Health, Inc. | 4.3 Billion USD | 99.994% |
P3 Health Partners Inc. | 1.26 Billion USD | 99.98% |
P3 Health Partners Inc. | 1.26 Billion USD | 99.98% |
The Pennant Group, Inc. | 544.89 Million USD | 99.953% |
Surgery Partners, Inc. | 2.74 Billion USD | 99.991% |
Syra Health Corp. Class A Common Stock | 5.51 Million USD | 95.376% |
Talkspace, Inc. | 150.04 Million USD | 99.83% |
Talkspace, Inc. | 150.04 Million USD | 99.83% |
The Oncology Institute, Inc. | 324.23 Million USD | 99.921% |
The Oncology Institute, Inc. | 324.23 Million USD | 99.921% |